TLDR Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.
The 2017 article "Is Dihydrotestosterone a Classic Hormone?" examined the role of dihydrotestosterone (DHT) in human physiology. The authors found that DHT, traditionally seen as a major sex steroid hormone in men, primarily acts as a paracrine hormone, affecting nearby cells rather than circulating throughout the body. The study revealed that the prostate and skin self-regulate DHT concentrations independently of serum DHT concentrations. It was also noted that exogenous testosterone therapy for male hypogonadism or androgen-based male hormonal contraceptives is unlikely to significantly change the prostate hormonal environment or the potential risk of prostate cancer. The article also stated that DHT does not seem to play a primary role in the development of male or female androgenic alopecia or acne. The authors concluded that further research is needed to understand DHT's physiological effects, including its specific role in cardiovascular health, sexual function, and bone health.
111 citations
,
August 2015 in “Reviews in Endocrine and Metabolic Disorders” 5α-reductase inhibitors may cause persistent sexual dysfunction and depression, needing more research on long-term effects.
71 citations
,
November 2012 in “Expert Opinion on Drug Safety” 5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.
124 citations
,
March 2012 in “JAMA” Testosterone's muscle-building effects do not require its conversion to DHT.
72 citations
,
April 2008 in “The Journal of urology/The journal of urology” Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.
195 citations
,
February 2007 in “The Journal of Clinical Endocrinology and Metabolism” Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.
417 citations
,
February 2004 in “The Journal of Clinical Endocrinology and Metabolism” Testosterone therapy increases bone density in older men with low testosterone levels.
1040 citations
,
October 1992 in “The New England Journal of Medicine” Finasteride effectively treats BPH but may increase sexual dysfunction risk.
30 citations
,
August 1992 in “The Journal of Clinical Endocrinology and Metabolism” Finasteride doesn't affect hormone levels in normal men.